Tirzepatide in Participants with Impaired Liver Function

A Study of Tirzepatide in Participants With Impaired Liver Function

The purpose of this study is to assess how fast tirzepatide gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants. The study will last about two months and will include five visits to the study center.

Pharmaceutical medication involved
Patients and healthy individuals accepted

Drug - Tirzepatide

Administered SC

A Single Dose Pharmacokinetic Study of Tirzepatide in Subjects With Varying Degrees of Hepatic Impairment